Table 2.
Technologies used in HSCs transplantation.
| Total | Multiple Sclerosis | Systemic Sclerosis | Rheumatoid arthritis | Juvenile idiopathic arthritis | Systemic Lupus Erythematosus | Immune Thrombocytopenia | P-value | |
|---|---|---|---|---|---|---|---|---|
| Source of stem cell | 0.0001 | |||||||
| BM | 54 | 12 | 2 | 1 | 23 | 11 | 2 | |
| BM ± PB | 419 | 138 | 69 | 69 | 28 | 51 | 8 | |
| Mobilization of peripheral blood | 0.0001 | |||||||
| GF | 89 | 15 | 7 | 41 | 9 | 2 | 4 | |
| Cy ± GF | 289 | 112 | 59 | 28 | 13 | 43 | 2 | |
| Others | 42 | 11 | 4 | 0 | 6 | 6 | 2 | |
| Conditioning | 0.0001 | |||||||
| Cy | 117 | 2 | 38 | 63 | 0 | 1 | 3 | |
| Cy + ATG + drugs | 127 | 22 | 23 | 3 | 21 | 34 | 3 | |
| Cy + radiation | 48 | 13 | 2 | 0 | 19 | 12 | 0 | |
| Bu + Cy | 24 | 16 | 0 | 2 | 1 | 1 | 1 | |
| BEAM + ATG | 92 | 82 | 1 | 0 | 0 | 4 | 1 | |
| Other | 23 | 3 | 1 | 1 | 4 | 3 | 2 | |
| Intensity | 0.0001 | |||||||
| High | 72 | 29 | 2 | 2 | 20 | 13 | 1 | |
| Intermediate | 225 | 105 | 25 | 3 | 23 | 40 | 4 | |
| Low | 134 | 4 | 38 | 64 | 2 | 2 | 5 | |
| In vitro purging | 0.0001 | |||||||
| CD 34 selection | 213 | 60 | 46 | 38 | 21 | 24 | 4 | |
| CD selection ± T B depletion | 36 | 12 | 9 | 2 | 5 | 2 | 1 | |
| T/B depletion | 17 | 4 | 1 | 0 | 11 | 0 | 1 | |
| Chemotherapy | 19 | 3 | 0 | 1 | 5 | 1 | 1 | |
ATG: anti-thymocyte globulin. Cy: cyclophosphamide. Bu: busulfan. BEAM: polychemotherapy. T/B: T/B cell depletion.